Enigma of a rapid introduction of antiangiogenic therapy with bevacizumab in glioblastoma – a new era in the treatment of malignant brain tumours?

Authors

  • Roger Henriksson Department of Radiation Sciences & Oncology, Umeå University Hospital, Umeå, Sweden
  • Per Bergström Department of Radiation Sciences & Oncology, Umeå University Hospital, Umeå, Sweden
  • Mikael Johansson Department of Radiation Sciences & Oncology, Umeå University Hospital, Umeå, Sweden
  • Maria Sandström Department of Radiation Sciences & Oncology, Umeå University Hospital, Umeå, Sweden

DOI:

https://doi.org/10.1080/02841860802468112

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2009-01-01

How to Cite

Henriksson, R., Bergström, P., Johansson, M., & Sandström, M. (2009). Enigma of a rapid introduction of antiangiogenic therapy with bevacizumab in glioblastoma – a new era in the treatment of malignant brain tumours?. Acta Oncologica, 48(1), 6–8. https://doi.org/10.1080/02841860802468112

Issue

Vol. 48 No. 1 (2009): Acta Oncologica

Section

Editorial